Document is current

Any future updates will be listed below

Cost-effectiveness analysis of liraglutide versus sitagliptin or exenatide in patients with inadequately controlled Type 2 diabetes on oral antidiabetic drugs in Greece

Crossref DOI link: https://doi.org/10.1186/1472-6963-14-419

Published Online: 2014-09-22

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark